Firstly, it provides new insights into the correlation between elevated inflammatory biomarkers—such as CRP, IL-6, TNF-α, and fibrinogen—and gastrointestinal symptoms in HIV-positive patients on ART, particularly those with type II diabetes. Here, IL6 is linked to type 2 diabetes mellitus.